121 related articles for article (PubMed ID: 22307076)
21. Quantitative analysis of ERG expression and its splice isoforms in formalin-fixed, paraffin-embedded prostate cancer samples: association with seminal vesicle invasion and biochemical recurrence.
Hagen RM; Adamo P; Karamat S; Oxley J; Aning JJ; Gillatt D; Persad R; Ladomery MR; Rhodes A
Am J Clin Pathol; 2014 Oct; 142(4):533-40. PubMed ID: 25239421
[TBL] [Abstract][Full Text] [Related]
22. Delineation of TMPRSS2-ERG splice variants in prostate cancer.
Hu Y; Dobi A; Sreenath T; Cook C; Tadase AY; Ravindranath L; Cullen J; Furusato B; Chen Y; Thangapazham RL; Mohamed A; Sun C; Sesterhenn IA; McLeod DG; Petrovics G; Srivastava S
Clin Cancer Res; 2008 Aug; 14(15):4719-25. PubMed ID: 18676740
[TBL] [Abstract][Full Text] [Related]
23. The p42 variant of ETS1 protein rescues defective Fas-induced apoptosis in colon carcinoma cells.
Li R; Pei H; Papas T
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3876-81. PubMed ID: 10097131
[TBL] [Abstract][Full Text] [Related]
24. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells.
Krause WC; Shafi AA; Nakka M; Weigel NL
Int J Biochem Cell Biol; 2014 Sep; 54():49-59. PubMed ID: 25008967
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of potential regulatory signaling molecules correlate with androgen receptor splice variants AR-V7 and AR-V567es in prostate cancer metastasis.
Kiliccioglu I; Bilen CY; Sozen S; Konac E
Gene; 2021 Mar; 772():145377. PubMed ID: 33359129
[TBL] [Abstract][Full Text] [Related]
27. Alternative splicing of the vitamin D receptor modulates target gene expression and promotes ligand-independent functions.
Annalora AJ; Jozic M; Marcus CB; Iversen PL
Toxicol Appl Pharmacol; 2019 Feb; 364():55-67. PubMed ID: 30552932
[TBL] [Abstract][Full Text] [Related]
28. Thymomegaly, microsplenia, and defective homeostatic proliferation of peripheral lymphocytes in p51-Ets1 isoform-specific null mice.
Higuchi T; Bartel FO; Masuya M; Deguchi T; Henderson KW; Li R; Muise-Helmericks RC; Kern MJ; Watson DK; Spyropoulos DD
Mol Cell Biol; 2007 May; 27(9):3353-66. PubMed ID: 17339335
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of novel ETV4 splice variants in prostate cancer.
Cosi I; Moccia A; Pescucci C; Munagala U; Di Giorgio S; Sineo I; Conticello SG; Notaro R; De Angioletti M
Sci Rep; 2023 Mar; 13(1):5267. PubMed ID: 37002241
[TBL] [Abstract][Full Text] [Related]
30. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
31. miR-204 is dysregulated in metastatic prostate cancer in vitro.
Todorova K; Metodiev MV; Metodieva G; Zasheva D; Mincheff M; Hayrabedyan S
Mol Carcinog; 2016 Feb; 55(2):131-47. PubMed ID: 25630658
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA‑195‑5p is associated with cell proliferation, migration and invasion in prostate cancer and targets MIB1.
Chen B; Bai G; Ma X; Tan L; Xu H
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34698358
[TBL] [Abstract][Full Text] [Related]
33. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
[TBL] [Abstract][Full Text] [Related]
34. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
Rickman DS; Pflueger D; Moss B; VanDoren VE; Chen CX; de la Taille A; Kuefer R; Tewari AK; Setlur SR; Demichelis F; Rubin MA
Cancer Res; 2009 Apr; 69(7):2734-8. PubMed ID: 19293179
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of novel spliced variants of neuregulin 4 in prostate cancer.
Hayes NV; Blackburn E; Smart LV; Boyle MM; Russell GA; Frost TM; Morgan BJ; Baines AJ; Gullick WJ
Clin Cancer Res; 2007 Jun; 13(11):3147-55. PubMed ID: 17545517
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.
Shafi AA; Putluri V; Arnold JM; Tsouko E; Maity S; Roberts JM; Coarfa C; Frigo DE; Putluri N; Sreekumar A; Weigel NL
Oncotarget; 2015 Oct; 6(31):31997-2012. PubMed ID: 26378018
[TBL] [Abstract][Full Text] [Related]
37. Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor.
Watson PA; Chen YF; Balbas MD; Wongvipat J; Socci ND; Viale A; Kim K; Sawyers CL
Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16759-65. PubMed ID: 20823238
[TBL] [Abstract][Full Text] [Related]
38. Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma.
Camões MJ; Paulo P; Ribeiro FR; Barros-Silva JD; Almeida M; Costa VL; Cerveira N; Skotheim RI; Lothe RA; Henrique R; Jerónimo C; Teixeira MR
PLoS One; 2012; 7(11):e49819. PubMed ID: 23185447
[TBL] [Abstract][Full Text] [Related]
39. Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line.
Marcias G; Erdmann E; Lapouge G; Siebert C; Barthélémy P; Duclos B; Bergerat JP; Céraline J; Kurtz JE
Hum Mutat; 2010 Jan; 31(1):74-80. PubMed ID: 19830810
[TBL] [Abstract][Full Text] [Related]
40. Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.
Dehm SM; Schmidt LJ; Heemers HV; Vessella RL; Tindall DJ
Cancer Res; 2008 Jul; 68(13):5469-77. PubMed ID: 18593950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
